A detailed history of Torno Capital, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Torno Capital, LLC holds 9,900 shares of IONS stock, worth $352,737. This represents 0.06% of its overall portfolio holdings.

Number of Shares
9,900
Holding current value
$352,737
% of portfolio
0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$40.06 - $51.86 $200,300 - $259,300
5,000 New
5,000 $200 Million
Q1 2024

May 15, 2024

BUY
$42.03 - $53.55 $231,165 - $294,525
5,500 Added 220.0%
8,000 $347 Million
Q4 2023

Feb 14, 2024

BUY
$43.39 - $51.63 $108,475 - $129,075
2,500 New
2,500 $126 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.06B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Torno Capital, LLC Portfolio

Follow Torno Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Torno Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Torno Capital, LLC with notifications on news.